Pharmacologic and pharmacokinetic properties of methocarbamol in the horse.

The research article explores the effects and behaviors of the drug methocarbamol when administered intravenously in horses. Crucially, the study found that the drug did not influence heart rate, respiratory rate, or behavior, suggesting it could be safely used in this species.

Effects of Methocarbamol

• The research observed the impact of methocarbamol, a muscle relaxant, on horses’ hemodynamics, respiration, and behavior.
• Three doses were administered intravenously (4.4, 8.8, 17.6 mg/kg) and their effects mapped over time.
• The results showed that vital signs, including heart rate, cardiac output, arterial and venous blood pressures, respiratory rate, and arterial blood gas levels, remained constant following the drug’s administration.
• Additionally, there were no noticeable changes in the horses’ behavior, and no signs of ataxia (a degenerative disease of the nervous system).

Pharmacokinetics of Methocarbamol

• The study also delved into the pharmacokinetic properties of methocarbamol, essentially how the drug moves through the horse’s body, including absorption, distribution, metabolism, and excretion.
• The scientists found that the disposition of methocarbamol appears to be dose-dependent i.e., the way the body processes and eliminates the drug changes with the amount administered.
• With an increase in dose, the so-called “clearance” (how quickly the drug is eliminated from the body) and “steady-state volume of distribution” (a measure of how widely the drug is dispersed throughout the body) decreased. This indicates that at higher doses, the drug stays in the horse’s body for longer periods.

Methocarbamol Metabolization

• In addition to the pharmacokinetics of methocarbamol itself, the researchers investigated its metabolite, guaifenesin.
• Despite methocarbamol being metabolized into guaifenesin, the plasma concentrations of the latter were found to be minimal, never exceeding 0.5% of the plasma concentration of the parent drug methocarbamol.
• This suggests that most of the administered methocarbamol stays as the original compound and does not significantly convert into its metabolite.